BerGenBio’s Board of Directors is composed of experienced biopharmaceutical executives with experience of developing next generation cancer drugs and building world class innovative oncology biotechnology companies. The Board also represents leading investors and has substantial commercial experience to navigate the development of the Company.
Board of Directors
Mr. Sveinung Hole
Non-Executive Director
Sveinung Hole is the CEO of Trond Mohn Foundation and…
Read More
Dr. Debra Barker
Non-Executive Director
Debra Barker is a seasoned clinical development executive with experience…
Read More
Dr. Sally Bennett
Non-Executive Director
Dr Sally Bennett has a career spanning medicine, equity and…
Read More
Dr. François Thomas
Non-Executive Director
François Thomas has more than 25 years of experience in…
Read More
Photo: Nils Olav Mevatne
